Cargando…
Selective targeting of liver cancer with the endothelial marker CD146
Hepatocellular carcinomas are well-vascularized tumors; the endothelial cells in these tumors have a specific phenotype. Our aim was to develop a new approach for tumor-specific drug delivery with monoclonal antibody targeting of endothelial ligands. CD146, a molecule expressed on the endothelial su...
Autores principales: | Thomann, Stefan, Longerich, Thomas, Bazhin, Alexandr V., Mier, Walter, Schemmer, Peter, Ryschich, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226708/ https://www.ncbi.nlm.nih.gov/pubmed/25238265 |
Ejemplares similares
-
Impact of wall shear stress and ligand avidity on binding of anti-CD146-coated nanoparticles to murine tumor endothelium under flow
por: Thomann, Stefan, et al.
Publicado: (2015) -
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS
por: Duan, Hongxia, et al.
Publicado: (2013) -
CD144, CD146 and VEGFR-2 properly identify circulating endothelial cell
por: Flores-Nascimento, Mariane Cristina, et al.
Publicado: (2015) -
Therapeutic Targeting Cancer-Initiating Cell Markers by Exosome miRNA: Efficacy and Functional Consequences Exemplified for claudin7 and EpCAM()
por: Kyuno, Daisuke, et al.
Publicado: (2018) -
Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
por: Salnikov, Alexei V, et al.
Publicado: (2009)